Veverimer

维瑞聚姆

Report date: 2026/04/15 20:02:38
NME

Base Information

Drug NameVeverimer
Drug Alias NameTRC-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsFatigueInsulin ResistanceDiabetes Mellitus +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumArmenia +[36] 
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesTricida Inc
China Registration ClassN/A

Develop Information

Active CompaniesRenibus Therapeutics IncThe University Of California DavisTufts Medical Center Inc +[4] 
Inactive CompaniesN/A
Active IndicationsFatigueInsulin ResistanceDiabetes Mellitus +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A